PL439409A1 - Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu - Google Patents
Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachuInfo
- Publication number
- PL439409A1 PL439409A1 PL439409A PL43940921A PL439409A1 PL 439409 A1 PL439409 A1 PL 439409A1 PL 439409 A PL439409 A PL 439409A PL 43940921 A PL43940921 A PL 43940921A PL 439409 A1 PL439409 A1 PL 439409A1
- Authority
- PL
- Poland
- Prior art keywords
- fragrance
- nicotine
- composition
- diffuser
- version
- Prior art date
Links
- 239000003205 fragrance Substances 0.000 title abstract 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 9
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 8
- 229960002715 nicotine Drugs 0.000 abstract 8
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 6
- 239000000796 flavoring agent Substances 0.000 abstract 3
- 235000019634 flavors Nutrition 0.000 abstract 3
- 235000011187 glycerol Nutrition 0.000 abstract 3
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
- A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Addiction (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Przedmiotem zgłoszenia jest kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu utworzona przez zmieszane ze sobą składniki. Kompozycja ta charakteryzuje się tym, że zawiera: od 40,0% do 45,0% glikolu propylenowego; od 40,0% do 45,0% gliceryny, od 8,0% do 10,0% aromatów, od 0,0% do 0,5% etanolu, nikotynę. Kompozycja w pierwszej swojej wersji zawiera: 0,3% nikotyny. Kompozycja zapachowa w drugiej swojej wersji zawiera 0,6% nikotyny. Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu utworzona przez zmieszane ze sobą składniki w trzeciej wersji zawiera: od 40,0% do 43,0% glikolu propylenowego, od 40,0% do 43,0% gliceryny, od 8,0% do 10,0% aromatów, od 0,0% do 0,5% etanol, 1,2% nikotyny. Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu utworzona przez zmieszane ze sobą składniki charakteryzuje się tym, że zawiera: od 38,0% do 42,0% glikolu propylenowego, od 38,0% do 42,0% gliceryny, od 8,0% do 10,0% aromatów, od 0,0% do 0,5% etanolu, nikotynę, przy czym w czwartej wersji zawiera 1,8% nikotyny, w piątej wersji zawiera 3,6% nikotyny, a w szóstej wersji zawiera 7,2 % nikotyny.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439409A PL439409A1 (pl) | 2021-11-03 | 2021-11-03 | Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL439409A PL439409A1 (pl) | 2021-11-03 | 2021-11-03 | Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL439409A1 true PL439409A1 (pl) | 2022-05-09 |
Family
ID=81534693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL439409A PL439409A1 (pl) | 2021-11-03 | 2021-11-03 | Kompozycja zapachowa przeznaczona do wprowadzania do dyfuzora zapachu |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL439409A1 (pl) |
-
2021
- 2021-11-03 PL PL439409A patent/PL439409A1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060978L (no) | Farmasoytiske blandingr for behandling av prematur ejakulasjon ved pulmonal inhalering | |
| BRPI0714417B8 (pt) | método para fabricar uma composição de cuidado oral, de cuidado pessoal, limpadora e/ou de cuidado doméstico | |
| EP4454703A3 (en) | Pharmaceutical compositions with low amounts of nitrosamine impurities and methods for producing the same | |
| TW200626558A (en) | Indazolone derivatives | |
| CY1107906T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου | |
| NO20076053L (no) | Pyrazolpyrimidinderivat for behandling og forebygging av leversykdom | |
| SA522431498B1 (ar) | مشتقات 3، 6-داي أمينو-بيريدازين-3-يل، تركيبات صيدلية تحتوي عليها واستخدامها في صورة عوامل مساعدة على تلاشي الخلايا | |
| BR112019002199A2 (pt) | composto, composição de aquecimento, composição aromatizante ou de fragrância, composição tópica, produto de consumo e método para melhorar, aperfeiçoar ou modificar as propriedades de sabor ou de odor de uma composição aromatizante ou de fragrância | |
| CR20230531A (es) | Composiciones de anticuerpos anti-tslp y usos de las mismas | |
| MX2010007745A (es) | Mezcla modificadora de reologia. | |
| NO20073762L (no) | Visko-supplementsammensetning og fremgangsmater | |
| UA87841C2 (ru) | Композиция, которая содержит амброксол, для местного применения | |
| SG158869A1 (en) | A tetracycline metal complex in a solid dosage form | |
| PL434762A1 (pl) | Środek wiążący do materiałów zawierających celulozę i zawierający go produkt | |
| MX2021006190A (es) | Composiciones antitranspirantes sin aluminio. | |
| DE60309200D1 (de) | Aliphatische verbindungen als duftstoffe mit moschuscharakter | |
| EA200800299A1 (ru) | Водные анестезирующие композиции, содержащие пропофол | |
| AR046213A1 (es) | Forma de presentacion del naproxeno sodico | |
| TW200612962A (en) | Estriol and estetrol prodrugs | |
| MX2023003147A (es) | Mezclas de polisorbato que tienen distribucion de esteres de acidos grasos modificados. | |
| GEP20125563B (en) | 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same | |
| PL431521A1 (pl) | Kompozycja wspomagająca mineralizację zębów w postaci tabletki pudrowej | |
| CN309515015S (zh) | 香薰机 | |
| MX2023013475A (es) | Uso de una nueva combinacion de disolventes para fragancias. | |
| CN309538049S (zh) | 多功能香膏散香器 |